Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 7861 AL 7875

Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature

Swift IJ, Bocchetta M, Benotmane H, Woollacott IO, Shafei R, Rohrer JD.

Neurobiol Aging. 2021 Mar;99:100.e9-100.e15. doi: 10.1016/j.neurobiolaging.2020.08.014. Epub 2020 Aug 25.

β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodies

Ferreira D, Przybelski SA, Lesnick TG, Lemstra AW, Londos E, Blanc F, Nedelska Z, Schwarz CG, Graff-Radford J, Senjem ML, Fields JA, Knopman DS, Savica R, Ferman TJ, Graff-Radford NR, Lowe VJ, Jack CR Jr, Petersen RC, Mollenhauer B, Garcia-Ptacek S, Abdelnour C, Hort J, Bonanni L, Oppedal K, Kramberger MG, Boeve BF, Aarsland D, Westman E, Kantarci K.

Neurology. 2020 Dec 15;95(24):e3257-e3268. doi: 10.1212/WNL.0000000000010943. Epub 2020 Sep 28.

Effectiveness of sorting tests for detecting cognitive decline in older adults with dementia and other common neurodegenerative disorders: A meta-analysis

Foran AM, Mathias JL, Bowden SC.

Neurosci Biobehav Rev. 2021 Jan;120:442-454. doi: 10.1016/j.neubiorev.2020.10.013. Epub 2020 Oct 20.

Body mass index and risk of Parkinson, Alzheimer, Dementia, and Dementia mortality: a systematic review and dose-response meta-analysis of cohort studies among 5 million participants

Rahmani J, Roudsari AH, Bawadi H, Clark C, Ryan PM, Salehisahlabadi A, Rahimi Sakak F, Goodarzi N, Razaz JM.

Nutr Neurosci. 2022 Mar;25(3):423-431. doi: 10.1080/1028415X.2020.1758888. Epub 2020 Oct 27.

[Dementia with Lewy bodies in a patient with oromandibular dystonia]

Yudina VV, Voskresenskaya ON, Yudina GK.

Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(7):109-112. doi: 10.17116/jnevro2020120071109.

A Systematic Review of Rehabilitation for Corticobulbar Symptoms in Adults with Huntington's Disease

Burnip E, Wallace E, Gozdzikowska K, Huckabee ML.

J Huntingtons Dis. 2020;9(1):1-12. doi: 10.3233/JHD-190384.

Baseline Variables Associated with Functional Decline in 2CARE, A Randomized Clinical Trial in Huntington's Disease

McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators.

J Huntingtons Dis. 2020;9(1):47-58. doi: 10.3233/JHD-190391.

Huntington disease like 2 (HDL-2) with parkinsonism and abnormal DAT-SPECT - A novel observation

Mulroy E, Latorre A, Menozzi E, Teh PC, Magrinelli F, Bhatia KP.

Parkinsonism Relat Disord. 2020 Feb;71:46-48. doi: 10.1016/j.parkreldis.2020.01.008. Epub 2020 Jan 16.

Utility of the Parkinson's disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington's disease

Martinez-Horta S, Horta-Barba A, Perez-Perez J, Sampedro F, de Lucia N, De Michele G, Kehrer S, Priller J, Migliore S, Squitieri F, Castaldo A, Mariotti C, Mañanes V, Lopez-Sendon JL, Rodriguez N, Martinez-Descals A, Garcia-Ruiz P, Júlio F, Januário C, Delussi M, de Tommaso M, Noguera S, Ruiz-Idiago J, Sitek EJ, Nuzzi A, Pagonabarraga J, Kulisevsky J; Cognitive Phenotype Working Group of the European Huntington’s Disease Network.

J Neurol. 2020 May;267(5):1527-1535. doi: 10.1007/s00415-020-09730-6. Epub 2020 Feb 7.

Autoscopic phenomena as an atypical psychiatric presentation of Huntington's disease: A case report including longitudinal clinical and neuroimaging data

Martínez-Horta S, Perez-Perez J, Pagonabarraga J, Sampedro F, Horta-Barba A, Blanke O, Kulisevsky J.

Cortex. 2020 Apr;125:299-306. doi: 10.1016/j.cortex.2020.01.024. Epub 2020 Feb 8.

The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients

Anil M, Mason SL, Barker RA.

J Huntingtons Dis. 2020;9(3):275-282. doi: 10.3233/JHD-200404.

Montreal cognitive assessment for evaluating cognitive impairment in Huntington's disease: a systematic review

Rosca EC, Simu M.

CNS Spectr. 2022 Feb;27(1):27-45. doi: 10.1017/S1092852920001868. Epub 2020 Oct 7.

An individual patient analysis of the efficacy of using GPi-DBS to treat Huntington's disease

Yin Z, Bai Y, Zhang H, Liu H, Hu W, Meng F, Yang A, Zhang J.

Brain Stimul. 2020 Nov-Dec;13(6):1722-1731. doi: 10.1016/j.brs.2020.09.025. Epub 2020 Oct 8.

Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report

Palermo G, Mazzucchi S, Unti E, Bonuccelli U, Ceravolo R.

J Clin Psychopharmacol. 2020 Nov/Dec;40(6):628-630. doi: 10.1097/JCP.0000000000001295.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias